HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 169 filers reported holding HAEMONETICS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,029,000 | -2.3% | 78,799 | -23.5% | 0.01% | -6.7% |
| Q2 2018 | $9,237,000 | +3.2% | 102,994 | -15.8% | 0.02% | +7.1% |
| Q1 2018 | $8,951,000 | +12.6% | 122,351 | -10.6% | 0.01% | +16.7% |
| Q4 2017 | $7,948,000 | -86.6% | 136,843 | -92.6% | 0.01% | -86.5% |
| Q4 2015 | $59,476,000 | -17.8% | 1,844,774 | -17.6% | 0.09% | -19.8% |
| Q3 2015 | $72,391,000 | -25.1% | 2,239,841 | -4.1% | 0.11% | -15.9% |
| Q2 2015 | $96,620,000 | -8.3% | 2,336,063 | -0.4% | 0.13% | -7.7% |
| Q1 2015 | $105,382,000 | +19.9% | 2,345,971 | -0.1% | 0.14% | +21.2% |
| Q4 2014 | $87,895,000 | -11.4% | 2,348,871 | -17.4% | 0.12% | -12.6% |
| Q3 2014 | $99,247,000 | -3.9% | 2,842,114 | -2.9% | 0.14% | -2.9% |
| Q2 2014 | $103,248,000 | +4.1% | 2,926,524 | -3.8% | 0.14% | -2.1% |
| Q1 2014 | $99,161,000 | +145.6% | 3,042,669 | +217.5% | 0.14% | +140.7% |
| Q4 2013 | $40,369,000 | – | 958,209 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |